Sign in
PLRZ Stock Price, Chart, Stats & News
Polyrizon Ltd.
Save
Polyrizon Ltd. (PLRZ) does not currently pay a dividend.
15.11M
Market cap
–
Current P/E
–
Forward P/E
PLRZ chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -19.20% |
ROE | -26.12% |
D/E | – |
Interest coverage ratio | -1.20x |
PLRZ valuation
P/E | – |
P/S | – |
P/B | 0.92x |
P/CF | -5.48x |
P/FCF | -3.55x |
P/OCF | -5.48x |
PEG | -0.05x |
EV multiple | -3.10x |
About
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14, formulated to block nasal allergies; PL-15, aimed at combating COVID-19; and PL-16, for influenza prevention.
Similar securities
Based on sector and market capitalization
Report issue